2 min read

Signal — SMA20 × SMA50 Crossover (Experimental) - November 5, 2025

November 5 2025


What this signal is (quick)

We’re testing a medium-term trend crossover: the 20-day Simple Moving Average (SMA20) moving above the 50-day Simple Moving Average (SMA50) (buy-side) or below it (sell-side). SMA/SMA is slower than EMA-based models, usually fewer but steadier signals.
Today’s list uses end-of-day data for Nov 5, 2025 and is experimental while we calibrate live performance.


How we ranked today (reader version)

  • Trend posture: fresh SMA20 > SMA50 (up-cross) or SMA20 < SMA50 (down-cross) confirmed on daily close vs yesterday.
  • Overlays: insider net (open-market buys − sells), days-to-earnings, and 30-day analyst-update density (when present).
  • Headlines: same-day or very recent items to validate or stress-test the setup.
Note: Signals are research only, not trade advice. We’ll keep refining as the live dataset grows.

Buy-Side Signals — SMA20 > SMA50 (up-cross)

(from our Nov 5 scan; ordered by market cap)

Rank Ticker Company Sector Last ($) Near 52-W High Volume Thrust (×) RSI(14) Insider Net (USD) Days→Earnings Analyst Updates (30d)
1 MAR Marriott International, Inc. Consumer Cyclical 283.07 100% 1.77× 73.13
2 NBIX Neurocrine Biosciences, Inc. Healthcare 153.75 100% 3.05× 68.90 −$42,591
3 LMND Lemonade, Inc. Financial Services 78.73 100% 4.58× 85.46 −$297,308 0

Same-day / recent headlines

  • MAR — Marriott International: Q3 beat with raised FY25 outlook; luxury strength offset softness in lower-tier brands. Stock extended gains today on heavy volume. (Reuters)
  • NBIX — Neurocrine: Post-print coverage remains constructive after a strong Q3 and pipeline progress; note a small CEO open-market sale reported yesterday. (Yahoo Finance)
  • LMND — Lemonade: Reported Q3 this morning; revenue growth and outlook headlines drove a sharp move. (Business Wire)

Field notes

  • Volume Thrust (×) compares today vs 20-day average (≥1.5× often = accumulation).
  • Insider Net (USD) is open-market buys minus sells (dollar-weighted).
  • A dash means the field wasn’t present/resolved in today’s support files — no gaps were filled.

Sell-Side Signals — SMA20 < SMA50 (down-cross)

  • None flagged in today’s Nov 5 file. (If a symbol doesn’t appear in your CSV, we do not invent entries.)

Signals summary (today’s set)

  • Momentum posture: Three up-crosses, all pressing near 52-week highs with notable volume thrust — classic confirmation behavior for 20/50 crosses.
  • Overlays: Insider prints were net negative for NBIX and LMND in the recent window; no resolved insider net for MAR in today’s file. Earnings proximity flagged for LMND (0 days) via your calendar. (Investing.com)

Carlo’s Take (EverHint)

SMA20×SMA50 is a confirmation tool. I prefer tiered entries: start partial, add after 2–3 closes above the crossover band and a tight pause/flag.

  • MAR: Fundamentals and tape aligned; consider buy-the-dip toward SMA20 if RSI > 50 persists. (Reuters)
  • NBIX: Strong trend but mind insider softening; keep sizes modest and trail under last higher-low. (Yahoo Finance)
  • LMND: Very fast move post-print; high RSI suggests chasing risk — wait for pullback to rising SMA20 or a tight inside-day. (Business Wire)

Independent, data-driven signals. No hype, no paid promotions — just experimental market research from EverHint.